- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Kedar Upadhye steps down as Cipla Global CFO
Mumbai: Cipla has recently announced that Kedar Upadhye has, on February 4, 2022, resigned from the position of Global Chief Financial Officer and Key Managerial Personnel of the Company to pursue his professional aspirations beyond pharmaceutical / healthcare sector.
"Kedar Upadhye will serve his full notice period of three months i.e. upto close of business hours of May 3, 2022 and will continue in his current role as Global Chief Financial Officer and Key Managerial Personnel until relieved. The Board will announce the successor in due course," the company said in a BSE filing.
The organisation places on record its sincere appreciation towards his valuable contribution.
Following are comments from Mr. Kedar Upadhye and Mr. Umang Vohra on the development: Kedar Upadhye: "The last 5 years at Cipla have been extremely gratifying. Under the guidance of Samina Hamied, Umang Vohra and the entire Management Council we have delivered across our strategic priorities and have set strong management and governance processes. I would like to thank the Board, the Management Council and the entire Cipla family for their support over these years. This decision to pursue opportunities outside Cipla is based on the professional aspiration to look for challenges beyond Pharma/Healthcare".
Umang Vohra, MD & Global CEO: "Kedar has been an extremely valued colleague and a business partner. We thank him for his immense contribution in Cipla's transformation journey over the last 5 years and establishing many best-in-class and industry leading practices. We respect his decision to diversify after an extremely successful career in Pharma and wish him continued success in the future".
Read also: Cipla Independent Director Naina Lal Kidwai resigns
Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. The Company was founded by Khwaja Abdul Hamied in 1935 in Mumbai.
Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control, depression, and other medical conditions
Read also: AstraZeneca Pharma India Independent director Kimsuka Narsimhan steps down
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751